Literature DB >> 24903094

Alternative splicing of endothelial fibronectin is induced by disturbed hemodynamics and protects against hemorrhage of the vessel wall.

Patrick A Murphy1, Richard O Hynes2.   

Abstract

OBJECTIVE: Abnormally low-flow conditions, sensed by the arterial endothelium, promote aneurysm rupture. Fibronectin (FN) is among the most abundant extracellular matrix proteins and is strongly upregulated in human aneurysms, suggesting a possible role in disease progression. Altered FN splicing can result in the inclusion of EIIIA and EIIIB exons, generally not expressed in adult tissues. We sought to explore the regulation of FN and its splicing and their possible roles in the vascular response to disturbed flow. APPROACH AND
RESULTS: We induced low and reversing flow in mice by partial carotid ligation and assayed FN splicing in an endothelium-enriched intimal preparation. Inclusion of EIIIA and EIIIB was increased as early as 48 hours, with negligible increases in total FN expression. To test the function of EIIIA and EIIIB inclusion, we induced disturbed flow in EIIIAB(-/-) mice unable to include these exons and found that they developed focal lesions with hemorrhage and hypertrophy of the vessel wall. Acute deletion of floxed FN caused similar defects in response to disturbed flow, consistent with a requirement for the upregulation of the spliced isoforms, rather than a developmental defect. Recruited macrophages promote FN splicing because their depletion by clodronate liposomes blocked the increase in endothelial EIIIA and EIIIB inclusion in the carotid model.
CONCLUSIONS: These results uncover a protective mechanism in the inflamed intima that develops under disturbed flow, by showing that splicing of FN mRNA in the endothelium, induced by macrophages, inhibits hemorrhage of the vessel wall.
© 2014 American Heart Association, Inc.

Entities:  

Keywords:  alternative splicing; fibronectins; hemorrhage; macrophages

Mesh:

Substances:

Year:  2014        PMID: 24903094      PMCID: PMC4140979          DOI: 10.1161/ATVBAHA.114.303879

Source DB:  PubMed          Journal:  Arterioscler Thromb Vasc Biol        ISSN: 1079-5642            Impact factor:   8.311


  52 in total

1.  Comparative in vivo analysis of the atherosclerotic plaque targeting properties of eight human monoclonal antibodies.

Authors:  Michael Fiechter; Katharina Frey; Tim Fugmann; Philipp A Kaufmann; Dario Neri
Journal:  Atherosclerosis       Date:  2010-11-27       Impact factor: 5.162

2.  Fibronectin extra domain-A promotes hepatic stellate cell motility but not differentiation into myofibroblasts.

Authors:  Abby L Olsen; Bridget K Sackey; Cezary Marcinkiewicz; David Boettiger; Rebecca G Wells
Journal:  Gastroenterology       Date:  2011-12-24       Impact factor: 22.682

3.  Balloon catheterization induced arterial expression of embryonic fibronectins.

Authors:  D Dubin; J H Peters; L F Brown; B Logan; K C Kent; B Berse; S Berven; B Cercek; B G Sharifi; R E Pratt
Journal:  Arterioscler Thromb Vasc Biol       Date:  1995-11       Impact factor: 8.311

4.  Critical roles of macrophages in the formation of intracranial aneurysm.

Authors:  Yasuhisa Kanematsu; Miyuki Kanematsu; Chie Kurihara; Yoshiteru Tada; Tsung-Ling Tsou; Nico van Rooijen; Michael T Lawton; William L Young; Elena I Liang; Yoshitsugu Nuki; Tomoki Hashimoto
Journal:  Stroke       Date:  2010-11-24       Impact factor: 7.914

Review 5.  Atherosclerotic plaque progression and vulnerability to rupture: angiogenesis as a source of intraplaque hemorrhage.

Authors:  Renu Virmani; Frank D Kolodgie; Allen P Burke; Aloke V Finn; Herman K Gold; Thomas N Tulenko; Steven P Wrenn; Jagat Narula
Journal:  Arterioscler Thromb Vasc Biol       Date:  2005-07-21       Impact factor: 8.311

6.  Prothrombotic effects of fibronectin isoforms containing the EDA domain.

Authors:  Anil K Chauhan; Janka Kisucka; Maria R Cozzi; Meghan T Walsh; Federico A Moretti; Monica Battiston; Mario Mazzucato; Luigi De Marco; Francisco E Baralle; Denisa D Wagner; Andrés F Muro
Journal:  Arterioscler Thromb Vasc Biol       Date:  2007-11-08       Impact factor: 8.311

7.  Endogenous renovascular hypertension combined with low shear stress induces plaque rupture in apolipoprotein E-deficient mice.

Authors:  Shu-xuan Jin; Ling-hong Shen; Peng Nie; Wei Yuan; Liu-hua Hu; Dan-dan Li; Xue-jin Chen; Xiao-kun Zhang; Ben He
Journal:  Arterioscler Thromb Vasc Biol       Date:  2012-08-16       Impact factor: 8.311

Review 8.  The role of cellular adaptation to mechanical forces in atherosclerosis.

Authors:  Cornelia Hahn; Martin A Schwartz
Journal:  Arterioscler Thromb Vasc Biol       Date:  2008-09-11       Impact factor: 8.311

9.  An adventitial IL-6/MCP1 amplification loop accelerates macrophage-mediated vascular inflammation leading to aortic dissection in mice.

Authors:  Brian C Tieu; Chang Lee; Hong Sun; Wanda Lejeune; Adrian Recinos; Xiaoxi Ju; Heidi Spratt; Dong-Chuan Guo; Dianna Milewicz; Ronald G Tilton; Allan R Brasier
Journal:  J Clin Invest       Date:  2009-11-16       Impact factor: 14.808

10.  The subendothelial extracellular matrix modulates NF-kappaB activation by flow: a potential role in atherosclerosis.

Authors:  A Wayne Orr; John M Sanders; Melissa Bevard; Elizabeth Coleman; Ian J Sarembock; Martin Alexander Schwartz
Journal:  J Cell Biol       Date:  2005-04-04       Impact factor: 10.539

View more
  26 in total

Review 1.  Blood Brothers: Hemodynamics and Cell-Matrix Interactions in Endothelial Function.

Authors:  Arif Yurdagul; A Wayne Orr
Journal:  Antioxid Redox Signal       Date:  2016-02-19       Impact factor: 8.401

Review 2.  Metastasis of circulating tumor cells: favorable soil or suitable biomechanics, or both?

Authors:  Ana Sofia Azevedo; Gautier Follain; Shankar Patthabhiraman; Sébastien Harlepp; Jacky G Goetz
Journal:  Cell Adh Migr       Date:  2015-08-27       Impact factor: 3.405

3.  Noninvasive imaging of tumor progression, metastasis, and fibrosis using a nanobody targeting the extracellular matrix.

Authors:  Noor Jailkhani; Jessica R Ingram; Mohammad Rashidian; Steffen Rickelt; Chenxi Tian; Howard Mak; Zhigang Jiang; Hidde L Ploegh; Richard O Hynes
Journal:  Proc Natl Acad Sci U S A       Date:  2019-05-08       Impact factor: 11.205

4.  Alternatively spliced fibronectin extra domain A is required for hemangiogenic recovery upon bone marrow chemotherapy.

Authors:  Alessandro Malara; Cristian Gruppi; Giuseppe Celesti; Vittorio Abbonante; Gianluca Viarengo; Luigi Laghi; Luigi De Marco; Andrés F Muro; Alessandra Balduini
Journal:  Haematologica       Date:  2017-11-16       Impact factor: 9.941

Review 5.  Integrin signaling in atherosclerosis.

Authors:  Alexandra C Finney; Karen Y Stokes; Christopher B Pattillo; A Wayne Orr
Journal:  Cell Mol Life Sci       Date:  2017-02-28       Impact factor: 9.261

6.  α5 and αv integrins cooperate to regulate vascular smooth muscle and neural crest functions in vivo.

Authors:  Christopher J Turner; Kwabena Badu-Nkansah; Denise Crowley; Arjan van der Flier; Richard O Hynes
Journal:  Development       Date:  2015-02-15       Impact factor: 6.868

7.  Endothelial FN (Fibronectin) Deposition by α5β1 Integrins Drives Atherogenic Inflammation.

Authors:  Zaki Al-Yafeai; Arif Yurdagul; Jonette M Peretik; Mabruka Alfaidi; Patrick A Murphy; A Wayne Orr
Journal:  Arterioscler Thromb Vasc Biol       Date:  2018-11       Impact factor: 8.311

8.  Endothelial Myocyte Enhancer Factor 2c Inhibits Migration of Smooth Muscle Cells Through Fenestrations in the Internal Elastic Lamina.

Authors:  Yao Wei Lu; Anthony M Lowery; Li-Yan Sun; Harold A Singer; Guohao Dai; Alejandro P Adam; Peter A Vincent; John J Schwarz
Journal:  Arterioscler Thromb Vasc Biol       Date:  2017-05-04       Impact factor: 8.311

9.  MEF2 (Myocyte Enhancer Factor 2) Is Essential for Endothelial Homeostasis and the Atheroprotective Gene Expression Program.

Authors:  Yao Wei Lu; Nina Martino; Brennan D Gerlach; John M Lamar; Peter A Vincent; Alejandro P Adam; John J Schwarz
Journal:  Arterioscler Thromb Vasc Biol       Date:  2021-01-07       Impact factor: 8.311

10.  Alternative Splicing of FN (Fibronectin) Regulates the Composition of the Arterial Wall Under Low Flow.

Authors:  Patrick A Murphy; Noor Jailkhani; Sarah-Anne Nicholas; Amanda M Del Rosario; Jeremy L Balsbaugh; Shahinoor Begum; Amy Kimble; Richard O Hynes
Journal:  Arterioscler Thromb Vasc Biol       Date:  2020-11-19       Impact factor: 8.311

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.